Noriaki Moriyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Noriaki Moriyama has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
Shigeru Saito
32 shared publicationsKoki Shishido
21 shared publicationsFutoshi Yamanaka
20 shared publications- Tomoki Ochiai
Department of Cardiology, Shonan Kamakura General Hospital, Kamakura, Japan
17 shared publications Kazuki Tobita
Department of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital, Kamakura, Japan
15 shared publicationsShingo Mizuno
15 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (9) , 2130-2132
Assessment of Implantation With Intra-Annular Self-Expandable Device in Transcatheter Aortic Valve Replacement
- 1 September 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (9) , 2130-2132
Open AccessAssessment of Implantation With Intra-Annular Self-Expandable Device in Transcatheter Aortic Valve Replacement
- Open Access
- 10 August 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (42)
Sheath-Assisted Redo Left Bundle Branch Area Pacing Without Additional Venous Puncture
- 10 August 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (42)
Open AccessSheath-Assisted Redo Left Bundle Branch Area Pacing Without Additional Venous Puncture
- Open Access
- 30 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (8)
Successful termination of ventricular tachycardia by intrinsic antitachycardia pacing delivered from a left bundle branch area pacing lead: a case report
Background: Intrinsic antitachycardia pacing (iATP) is an advanced algorithm designed to optimize pacing sequences for ventricular tachycardia (VT) termination. Although left bundle branch area pacing (LBBAP) has emerged as a physiological pacing strategy and is increasingly incorporated into cardiac resynchronization therapy, its role as a delivery site for iATP remains unclear. Case summary: We report a 57-year-old man with advanced heart failure who underwent implantation of LBB–optimized cardiac resynchronization therapy with defibrillator for secondary prevention. During follow-up, multiple episodes of sustained VT with different morphologies were consistently and successfully terminated by iATP delivered exclusively from the LBBAP lead, without the need for conventional ATP or shock therapies. Discussion: This case suggests that conduction system pacing via the LBB area may provide a novel and effective substrate for antitachycardia pacing, potentially enabling more rapid engagement of re-entrant circuits through the His–Purkinje system. Further studies are warranted to establish the efficacy of iATP delivered from conduction system pacing leads.
- 30 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (8)
Open AccessSuccessful termination of ventricular tachycardia by intrinsic antitachycardia pacing delivered from a left bundle branch area pacing lead: a case report
Background: Intrinsic antitachycardia pacing (iATP) is an advanced algorithm designed to optimize pacing sequences for ventricular tachycardia (VT) termination. Although left bundle branch area pacing (LBBAP) has emerged as a physiological pacing strategy and is increasingly incorporated into cardiac resynchronization therapy, its role as a delivery site for iATP remains unclear. Case summary: We report a 57-year-old man with advanced heart failure who underwent implantation of LBB–optimized cardiac resynchronization therapy with defibrillator for secondary prevention. During follow-up, multiple episodes of sustained VT with different morphologies were consistently and successfully terminated by iATP delivered exclusively from the LBBAP lead, without the need for conventional ATP or shock therapies. Discussion: This case suggests that conduction system pacing via the LBB area may provide a novel and effective substrate for antitachycardia pacing, potentially enabling more rapid engagement of re-entrant circuits through the His–Purkinje system. Further studies are warranted to establish the efficacy of iATP delivered from conduction system pacing leads.
- Open Access
- 9 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Massive tricuspid regurgitation caused by iatrogenic papillary muscle rupture during leadless pacemaker retrieval: a case report
Background: Leadless pacemakers (LPMs) reduce complications associated with transvenous systems; however, tricuspid regurgitation (TR) caused by mechanical interference after LPM implantation has been reported. We describe a rare case of massive TR caused by papillary muscle rupture during LPM deployment and retrieval. Case summary: An 86-year-old man presented with syncope due to complete atrioventricular block. Because of his advanced age and limited activities of daily living, a leadless pacemaker was selected. During deployment, anterior papillary muscle became entrapped between the delivery sheath and the leadless pacemaker while recapturing. Subsequent retrieval resulted in papillary muscle rupture leading severe TR. The patient later underwent transvenous pacemaker implantation and recovered with medical therapy. Discussion: This case highlights a previously unreported mechanism of TR during LPM implantation—papillary muscle entrapment and rupture during device retrieval—which can lead to catastrophic tricuspid valve dysfunction.
- 9 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Open AccessMassive tricuspid regurgitation caused by iatrogenic papillary muscle rupture during leadless pacemaker retrieval: a case report
Background: Leadless pacemakers (LPMs) reduce complications associated with transvenous systems; however, tricuspid regurgitation (TR) caused by mechanical interference after LPM implantation has been reported. We describe a rare case of massive TR caused by papillary muscle rupture during LPM deployment and retrieval. Case summary: An 86-year-old man presented with syncope due to complete atrioventricular block. Because of his advanced age and limited activities of daily living, a leadless pacemaker was selected. During deployment, anterior papillary muscle became entrapped between the delivery sheath and the leadless pacemaker while recapturing. Subsequent retrieval resulted in papillary muscle rupture leading severe TR. The patient later underwent transvenous pacemaker implantation and recovered with medical therapy. Discussion: This case highlights a previously unreported mechanism of TR during LPM implantation—papillary muscle entrapment and rupture during device retrieval—which can lead to catastrophic tricuspid valve dysfunction.
- Open Access
- 20 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (16) , 107393
Is Aortic Regurgitation Associated With Long-Term Ergotamine Use?
- 20 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (16) , 107393
Open AccessIs Aortic Regurgitation Associated With Long-Term Ergotamine Use?
- Open Access
- 10 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (5) , 3109-3119
Outcomes of Fluoroscopy‐Based Asymmetric Underexpansion With the Self‐Expanding ACURATE Neo and Neo2 Valve
Background: Asymmetric underexpansion of transcatheter heart valves (THVs), as observed on fluoroscopy, may influence prosthesis function or long‐term durability of transcatheter aortic valve implantation (TAVI). Aims: This study aimed to evaluate the effect of stent frame asymmetry on hemodynamic performance and clinical outcomes in ACURATE neo and neo2 THVs. Methods: In a retrospective registry, the TAVI asymmetry index was defined as the ratio of the THV stent frame diameter. Patients were divided into three groups based on this ratio: a tubular shape, TAVI asymmetry index < 10% (group 1); a tapered shape, a bottom diameter at least 10% greater than the upper diameter (group 2); and a flared shape, an upper diameter at least 10% greater than the bottom diameter (group 3). Impaired THV hemodynamic performance was defined as a mean residual THV gradient ≥ 20 mmHg and/or at least moderate paravalvular regurgitation. Results: From December 2015 to 2023, 585 patients were included (group 1, n = 447; group 2, n = 96; and group 3, n = 47). Compared to group 1, groups 2 and 3 exhibited a higher incidence of impaired THV hemodynamic performance (4.9% vs. 17.5% vs. 11.9%; p < 0.001). There was no significant difference in all‐cause mortality or heart failure hospitalization at 3 years among the three groups ( p = 0.787). In multivariable analysis, stent frame asymmetry (groups 2 and 3) was an independent predictor of impaired THV hemodynamic performance. Conclusions: Stent frame asymmetry of ACURATE neo and neo2 was associated with impaired THV hemodynamic performance but not with clinical outcomes.
- 10 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (5) , 3109-3119
Open AccessOutcomes of Fluoroscopy‐Based Asymmetric Underexpansion With the Self‐Expanding ACURATE Neo and Neo2 Valve
Background: Asymmetric underexpansion of transcatheter heart valves (THVs), as observed on fluoroscopy, may influence prosthesis function or long‐term durability of transcatheter aortic valve implantation (TAVI). Aims: This study aimed to evaluate the effect of stent frame asymmetry on hemodynamic performance and clinical outcomes in ACURATE neo and neo2 THVs. Methods: In a retrospective registry, the TAVI asymmetry index was defined as the ratio of the THV stent frame diameter. Patients were divided into three groups based on this ratio: a tubular shape, TAVI asymmetry index < 10% (group 1); a tapered shape, a bottom diameter at least 10% greater than the upper diameter (group 2); and a flared shape, an upper diameter at least 10% greater than the bottom diameter (group 3). Impaired THV hemodynamic performance was defined as a mean residual THV gradient ≥ 20 mmHg and/or at least moderate paravalvular regurgitation. Results: From December 2015 to 2023, 585 patients were included (group 1, n = 447; group 2, n = 96; and group 3, n = 47). Compared to group 1, groups 2 and 3 exhibited a higher incidence of impaired THV hemodynamic performance (4.9% vs. 17.5% vs. 11.9%; p < 0.001). There was no significant difference in all‐cause mortality or heart failure hospitalization at 3 years among the three groups ( p = 0.787). In multivariable analysis, stent frame asymmetry (groups 2 and 3) was an independent predictor of impaired THV hemodynamic performance. Conclusions: Stent frame asymmetry of ACURATE neo and neo2 was associated with impaired THV hemodynamic performance but not with clinical outcomes.
- Open Access
Clinical and hemodynamic outcomes for transcatheter aortic valve implantation in internally stented surgical valve -Comparison of Balloon- and Self-Expandable Valves-
Background: Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is indicated in patients undergoing repeat interventions for degenerative aortic valve bioprostheses. Patients with internally stented surgical valves (IS) (Mitroflow and Trifecta) are at a high risk for coronary artery obstruction during the ViV procedure. This study aimed to evaluate the mid-term clinical and hemodynamic outcomes of balloon-expandable valves (BEV) and supra-annular self-expanding valves (SEV) for TAVI within the IS. Methods: Baseline characteristics, hemodynamic parameters, and clinical outcomes of patients who underwent ViV for IS treated with BEV and SEV were retrospectively collected. Outcomes were compared using propensity score matching (PSM). Results: In total, 113 patients were included this analysis. Sixty-three patients (55.8%) underwent BEV, and fifty patients (44.2%) underwent SEV. Overall, 37 pairs were identified after PSM. At 30-day, the clinical and hemodynamic outcomes were similar between the groups. Patients with SEV had better post-procedural mean gradient at 1-year compared with those with BEV (22.7±8.4 mmHg vs 11.7±4.3 mmHg; p<0.001). There was no significant difference between SEV and BEV in the cumulative 2-year composite endpoint, including all-cause of mortality, hospitalization for heart failure, and coronary obstruction (log-rank p=0.489) Conclusions: In patients who underwent ViV for IS, the early- and mid-term clinical outcomes were comparable between BEV and SEV. Meanwhile, the 1-year hemodynamics seemed to be better in patients with SEV than in those with BEV. Clinical Perspective: What is new? Mid-term clinical outcomes, including all-cause mortality, heart failure rehospitalization, and coronary obstruction, were similar between balloon-expandable valve (BEV) and self-expanding valve (SEV) in valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) for internally stented surgical valves (IS). SEV group has lower transvalvular gradients at 1-yearfollow-up than BEV group, while the occurrence of coronary obstruction were similar. What are the Clinical Implications? Individualized device selection and improving pre-operative screening for a risk of coronary obstruction, patient-specific anatomical and procedural factors can help the better clinical outcomes.
Open AccessClinical and hemodynamic outcomes for transcatheter aortic valve implantation in internally stented surgical valve -Comparison of Balloon- and Self-Expandable Valves-
Background: Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is indicated in patients undergoing repeat interventions for degenerative aortic valve bioprostheses. Patients with internally stented surgical valves (IS) (Mitroflow and Trifecta) are at a high risk for coronary artery obstruction during the ViV procedure. This study aimed to evaluate the mid-term clinical and hemodynamic outcomes of balloon-expandable valves (BEV) and supra-annular self-expanding valves (SEV) for TAVI within the IS. Methods: Baseline characteristics, hemodynamic parameters, and clinical outcomes of patients who underwent ViV for IS treated with BEV and SEV were retrospectively collected. Outcomes were compared using propensity score matching (PSM). Results: In total, 113 patients were included this analysis. Sixty-three patients (55.8%) underwent BEV, and fifty patients (44.2%) underwent SEV. Overall, 37 pairs were identified after PSM. At 30-day, the clinical and hemodynamic outcomes were similar between the groups. Patients with SEV had better post-procedural mean gradient at 1-year compared with those with BEV (22.7±8.4 mmHg vs 11.7±4.3 mmHg; p<0.001). There was no significant difference between SEV and BEV in the cumulative 2-year composite endpoint, including all-cause of mortality, hospitalization for heart failure, and coronary obstruction (log-rank p=0.489) Conclusions: In patients who underwent ViV for IS, the early- and mid-term clinical outcomes were comparable between BEV and SEV. Meanwhile, the 1-year hemodynamics seemed to be better in patients with SEV than in those with BEV. Clinical Perspective: What is new? Mid-term clinical outcomes, including all-cause mortality, heart failure rehospitalization, and coronary obstruction, were similar between balloon-expandable valve (BEV) and self-expanding valve (SEV) in valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) for internally stented surgical valves (IS). SEV group has lower transvalvular gradients at 1-yearfollow-up than BEV group, while the occurrence of coronary obstruction were similar. What are the Clinical Implications? Individualized device selection and improving pre-operative screening for a risk of coronary obstruction, patient-specific anatomical and procedural factors can help the better clinical outcomes.
- Open Access
- 29 May 2025
- Published by Elsevier in Structural Heart
- Vol. 9 (10)
Impact of Basal Septal Bulge on Conduction Disturbance After Transcatheter Aortic Valve Replacement Using ACURATE neo/neo2
- 29 May 2025
- Published by Elsevier in Structural Heart
- Vol. 9 (10)
Open AccessImpact of Basal Septal Bulge on Conduction Disturbance After Transcatheter Aortic Valve Replacement Using ACURATE neo/neo2
- Open Access
- 27 March 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (6) , 103274
Left Bundle Branch Area Pacing With TAVR
- 27 March 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (6) , 103274
Open AccessLeft Bundle Branch Area Pacing With TAVR